J. G. Dixon
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
.
Cancer.
2019
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
.
Journal of Neuro-Oncology.
2019
Contact
full name
J. G.
Dixon
Quick Info
Collaboration
Co-author network
Map of science